Sort
35,931 grants matching “parkinsons”
Cholinergic mechanisms of attentional-motor integration and gait dysfunction in Parkinson Disease
$2,334,226Roger L Albin · University Of Michigan At Ann Arbor · P50 · FY2023 · NS
The BrainCellQTL consortium: QTL mapping in the human brain at the single cell level
$2,333,781Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · U24 · FY2024 · AG
Morris K. Udall Centers of Excellence for Parkinson's Disease Research at Emory University
$2,332,955Thomas N. Wichmann · Emory University · P50 · FY2025 · NS
Molecular Dissection of Mitochondria-Organelle Interactions
$2,332,500Yasemin S Sancak · University Of Washington · DP2 · FY2020 · ES
Investigations of Dementia in Parkinson Disease
$2,332,494Joel Synes Perlmutter · Washington University · RF1 · FY2023 · NS
Cell Biology Of Genetic Neurodegenerative Disorders
$2,332,378Mark R Cookson · Aging · Z01 · FY2007 · AG
The lipid amidase NAAA as a therapeutic target for Alzheimer's disease
$2,328,624Daniele Piomelli · University Of California-Irvine · RF1 · FY2020 · AG
Effects-Related Biomarkers of Environmental Neurotoxic Exposures
$2,327,099Harvey Checkoway · University Of Washington · P42 · FY2011 · ES
Cholinergic mechanisms of attentional-motor integration and gait dysfunction in Parkinson Disease
$2,325,657Roger L Albin · University Of Michigan At Ann Arbor · P50 · FY2025 · NS
Molecular signaling during development and maturation of the nervous system
$2,324,894David Talmage · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Pro-inflammatory cytokine lowering anti-inflammatory drugs
$2,323,536Nigel H. Greig · National Institute On Aging · ZIA · FY2024 · AG
Neuroprotection Studies in PD: A Coordinating Center
$2,321,905Karl D. Kieburtz · University Of Rochester · U01 · FY2011 · NS
NIEHS Cryo-EM Core Facility
$2,321,261Mario Borgnia · National Institute Of Environmental Health Sciences · ZIC · FY2024 · ES
National Resource for Mass Spectrom of Biological Macromolecules
$2,320,963Brian T Chait · Rockefeller University · P41 · FY2013 · GM
Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease
$2,320,945William T Dauer · University Of Michigan At Ann Arbor · P50 · FY2014 · NS
Combinatorial approaches for studying multiple cues regulating human pluripotent
$2,317,750Kibum Lee · Rutgers, The State Univ Of N.J. · DP2 · FY2009 · OD
Epidemiology of Dementia In An Urban Community
$2,313,454Columbia University Health Sciences · P01 · FY2004 · AG
"Genetic and clinical studies of Gaucher disease and other lysosomal disorders"
$2,311,582Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2012 · HG
Engineering Ubiquitin Ligases to Investigate Protein Aggregation and Neurodegener
$2,310,000Shu-Bing Qian · Cornell University · DP2 · FY2009 · OD
Epidemiology of Dementia In An Urban Community
$2,308,243Richard Mayeux · Columbia University Health Sciences · P01 · FY2007 · AG
Molecular And Pharmacological Studies Of Dopamine Receptors
$2,308,197David Sibley · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
Watching Proteins Fold (or Misfold) in vivo with Mass Spectrometry
$2,308,098Stephen David Fried · Johns Hopkins University · DP2 · FY2020 · GM
Leveraging a Natural Experiment to Determine the Effects of Integrated Palliative Care on Health Service Outcomes and Disparities in Parkinson Disease and Lewy Body Dementia
$2,307,536Allison Willis · University Of Pennsylvania · RF1 · FY2023 · NS
Effects-Related Biomarkers of Environmental Neurotoxic Exposures
$2,306,175Harvey Checkoway · University Of Washington · P42 · FY2012 · ES
The Impact of Beta- and Gamma-Synucleins on Alpha-Synuclein's Synaptic Function
$2,305,682Jacqueline Burre · Weill Medical Coll Of Cornell Univ · RF1 · FY2022 · NS